Cofactor Genomics unveils new data supporting novel OncoPrism diagnostics
Cofactor Genomics, a predictive immune modeling company, today presented initial results from the multi-center clinical study PREDAPT (Predicting Immunotherapy Efficacy From Analysis of Pre-Treatment Tumor